Ambulatoria Za Specializirana Medicinska Izvanboln Pomosht0medicinski Centar Sveti Panteleimon EOOD
- Address
- lock Available on a paid plan
Ambulatoria Za Specializirana Medicinska Izvanboln Pomosht - Medicinski Centar Sveti Panteleimon
Medicinski Centar Sveti Panteleimon is a specialized outpatient medical facility dedicated to advancing dermatological research and treatment. The center focuses on evaluating innovative therapeutic approaches for complex skin conditions affecting both adolescent and adult populations.
- Moderate to severe atopic dermatitis (eczema) treatment protocols
- Systemic therapy evaluation for chronic inflammatory skin conditions
- Advanced pharmacological interventions including JAK inhibitors
The center's research portfolio emphasizes efficacy and safety assessments of emerging treatments for patients with moderate to severe atopic dermatitis who require systemic therapeutic intervention. Through participation in multinational clinical trials, the facility contributes valuable data to support the development of next-generation dermatological therapies, particularly targeting chronic inflammatory conditions that significantly impact patient quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ambulatoria Za Specializirana Medicinska Izvanboln Pomosht0medicinski Centar Sveti Panteleimon EOOD
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of Upadacitinib in Adolescents and Adults with Moderate to Severe Atopic Dermatitis | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Jan 2019 | Nov 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Upadacitinib | 1 | Unknown | 2019-01-09 | 2019-01-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.